Generics in South Korea - Market Summary, Competitive Analysis and Forecast to 2025
![](/report_cover/4228/generics-in-south-korea-market-summary-competitive-analysis-n-forecast-to-2025_en.gif)
Generics in South Korea - Market @Summary, Competitive Analysis and Forecast to 2025
SUMMARY
Generics in South Korea industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Generics in South Korea industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
- The South Korean generics market had total revenues of $5.1bn in 2020, representing a compound annual growth rate (CAGR) of 4.3% between 2016 and 2020.
- Market consumption volume increased with a CAGR of 3% between 2016 and 2020, to reach a total of 77.5% in 2020.
- South Korea’s demographic makeup presents similar issues to those in other economies: rising incomes, a growing elderly population, and increased health insurance coverage, all of which are driving market growth.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in South Korea
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in South Korea
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the South Korea generics market with five year forecasts
- What was the size of the South Korea generics market by value in 2020?
- What will be the size of the South Korea generics market in 2025?
- What factors are affecting the strength of competition in the South Korea generics market?
- How has the market performed over the last five years?
- What are the main segments that make up South Korea's generics market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
3.2. Market volume
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
5.2. Market volume forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths/weaknesses of the leading players?
7.3. Has there been any significant recent M&A activity?
7.4. How has the COVID-19 pandemic impacted leading players?
8 COMPANY PROFILES
8.1. Pfizer Inc.
8.2. Teva Pharmaceutical Industries Limited
8.3. Yuhan Corp
8.4. Viatris Inc.
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
3.2. Market volume
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
5.2. Market volume forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths/weaknesses of the leading players?
7.3. Has there been any significant recent M&A activity?
7.4. How has the COVID-19 pandemic impacted leading players?
8 COMPANY PROFILES
8.1. Pfizer Inc.
8.2. Teva Pharmaceutical Industries Limited
8.3. Yuhan Corp
8.4. Viatris Inc.
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: South Korea generics market value: $ million, 2016-20
Table 2: South Korea generics market volume: %, 2016-20
Table 3: South Korea generics market geography segmentation: $ million, 2020
Table 4: South Korea generics market value forecast: $ million, 2020-25
Table 5: South Korea generics market volume forecast: %, 2020-25
Table 6: Pfizer Inc.: key facts
Table 7: Pfizer Inc.: Annual Financial Ratios
Table 8: Pfizer Inc.: Key Employees
Table 9: Pfizer Inc.: Key Employees Continued
Table 10: Teva Pharmaceutical Industries Limited: key facts
Table 11: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 12: Teva Pharmaceutical Industries Limited: Key Employees
Table 13: Yuhan Corp: key facts
Table 14: Yuhan Corp: Annual Financial Ratios
Table 15: Yuhan Corp: Key Employees
Table 16: Viatris Inc.: key facts
Table 17: Viatris Inc.: Annual Financial Ratios
Table 18: Viatris Inc.: Key Employees
Table 19: South Korea size of population (million), 2016-20
Table 20: South Korea gdp (constant 2005 prices, $ billion), 2016-20
Table 21: South Korea gdp (current prices, $ billion), 2016-20
Table 22: South Korea inflation, 2016-20
Table 23: South Korea consumer price index (absolute), 2016-20
Table 24: South Korea exchange rate, 2016-20
Table 1: South Korea generics market value: $ million, 2016-20
Table 2: South Korea generics market volume: %, 2016-20
Table 3: South Korea generics market geography segmentation: $ million, 2020
Table 4: South Korea generics market value forecast: $ million, 2020-25
Table 5: South Korea generics market volume forecast: %, 2020-25
Table 6: Pfizer Inc.: key facts
Table 7: Pfizer Inc.: Annual Financial Ratios
Table 8: Pfizer Inc.: Key Employees
Table 9: Pfizer Inc.: Key Employees Continued
Table 10: Teva Pharmaceutical Industries Limited: key facts
Table 11: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 12: Teva Pharmaceutical Industries Limited: Key Employees
Table 13: Yuhan Corp: key facts
Table 14: Yuhan Corp: Annual Financial Ratios
Table 15: Yuhan Corp: Key Employees
Table 16: Viatris Inc.: key facts
Table 17: Viatris Inc.: Annual Financial Ratios
Table 18: Viatris Inc.: Key Employees
Table 19: South Korea size of population (million), 2016-20
Table 20: South Korea gdp (constant 2005 prices, $ billion), 2016-20
Table 21: South Korea gdp (current prices, $ billion), 2016-20
Table 22: South Korea inflation, 2016-20
Table 23: South Korea consumer price index (absolute), 2016-20
Table 24: South Korea exchange rate, 2016-20
LIST OF FIGURES
Figure 1: South Korea generics market value: $ million, 2016-20
Figure 2: South Korea generics market volume: %, 2016-20
Figure 3: South Korea generics market geography segmentation: % share, by value, 2020
Figure 4: South Korea generics market value forecast: $ million, 2020-25
Figure 5: South Korea generics market volume forecast: %, 2020-25
Figure 6: Forces driving competition in the generics market in South Korea, 2020
Figure 7: Drivers of buyer power in the generics market in South Korea, 2020
Figure 8: Drivers of supplier power in the generics market in South Korea, 2020
Figure 9: Factors influencing the likelihood of new entrants in the generics market in South Korea, 2020
Figure 10: Factors influencing the threat of substitutes in the generics market in South Korea, 2020
Figure 11: Drivers of degree of rivalry in the generics market in South Korea, 2020
Figure 1: South Korea generics market value: $ million, 2016-20
Figure 2: South Korea generics market volume: %, 2016-20
Figure 3: South Korea generics market geography segmentation: % share, by value, 2020
Figure 4: South Korea generics market value forecast: $ million, 2020-25
Figure 5: South Korea generics market volume forecast: %, 2020-25
Figure 6: Forces driving competition in the generics market in South Korea, 2020
Figure 7: Drivers of buyer power in the generics market in South Korea, 2020
Figure 8: Drivers of supplier power in the generics market in South Korea, 2020
Figure 9: Factors influencing the likelihood of new entrants in the generics market in South Korea, 2020
Figure 10: Factors influencing the threat of substitutes in the generics market in South Korea, 2020
Figure 11: Drivers of degree of rivalry in the generics market in South Korea, 2020